Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -71250.0% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1768.6 | n/a |
Pr/Book | 3.0 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (0.95) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (1.57) | (0.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (1.84) | (0.85)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (1.19) | (0.55)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (1.42) | (0.52)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 29-Apr-2025 | 16:25 | RNS |
Holding(s) in Company | 29-Apr-2025 | 11:05 | RNS |
Holding(s) in Company | 28-Apr-2025 | 14:30 | RNS |
N4 Pharma files for new UK patent | 04-Dec-2024 | ShareCast |
N4 Pharma reports positive progress with SRI col... | 20-Aug-2024 | ShareCast |
N4 Pharma shares tank after £0.6m fundraise | 07-Jun-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.43p |
Change Today | 0.050p |
% Change | 13.33 % |
52 Week High | 3.07p |
52 Week Low | 0.35p |
Volume | 1,799,756 |
Shares Issued | 832.28m |
Market Cap | £3.54m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:58 | 50,000 @ 0.44p |
15:42 | 374,045 @ 0.44p |
15:05 | 11,000 @ 0.40p |
15:05 | 150,000 @ 0.40p |
11:36 | 500 @ 0.40p |
You are here: research